Loading...
Assessing Outcomes in Prostate Cancer Clinical Trials: A 21st Century Tower of Babel
BACKGROUND: Due to the osseous distribution of prostate cancer metastases, progression is more readily identified than response in prostate cancer clinical trials. As a result, there is an increased focus on progression free survival (PFS) as a phase II endpoint. PFS, however, is vulnerable to inter...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2708077/ https://ncbi.nlm.nih.gov/pubmed/18661513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.23719 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|